Request Demo
Last update 19 Oct 2025
Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)
Last update 19 Oct 2025
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms CA501 |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4857
The sequence is quoted from: *****
Sequence Code 91440
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)CTR20221898
多中心、随机、开放、平行对照比较德谷胰岛素注射液（CA501注射液）和诺和达®治疗2型糖尿病患者的有效性和安全性
[Translation] A multicenter, randomized, open, parallel controlled study to compare the efficacy and safety of insulin degludec injection (CA501 injection) and Tresiba® in the treatment of patients with type 2 diabetes
CTR20202081
德谷胰岛素注射液在健康人群中的随机、开放、单次给药、交叉设计的PK、PD比对试验。
[Translation] A randomized, open-label, single-dose, crossover PK and PD comparison study of degludec insulin injection in healthy people.
100 Clinical Results associated with Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)
Login to view more data
100 Translational Medicine associated with Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)
Login to view more data
100 Patents (Medical) associated with Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)
Login to view more data
100 Deals associated with Insulin degludec biosimilar (Chongqing Chenan Biopharmaceutical)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | NDA/BLA | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free